QuickView for SCN5A;jsessionid=8D857E12124C79A8310A471B97D36743;jsessionid=A1EB8E311668B5758323726C34AC0467;jsessionid=BC82641086CA3C3666C41CF05C1F95E2;jsessionid=2ACE0AEFF302B087936BAD76975B25CA;jsessionid=9B1888D8DE9735BADCDF87EB8D0A1893;jsessionid=54A8FB5DEF2C7BB13B405A18E615C6E9;jsessionid=DC81F27C1A01BEA89BD0E8E2A9F4D183 (gene)

1. SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond.
2. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation a…
3. The SCN5A Gene Is a Predictor of Phenotype Severity in Brugada Syndrome: A Comprehensive Literature …
4. Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblas…
5. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.

There were no clinical trials for SCN5A;jsessionid=8D857E12124C79A8310A471B97D36743;jsessionid=A1EB8E311668B5758323726C34AC0467;jsessionid=BC82641086CA3C3666C41CF05C1F95E2;jsessionid=2ACE0AEFF302B087936BAD76975B25CA;jsessionid=9B1888D8DE9735BADCDF87EB8D0A1893;jsessionid=54A8FB5DEF2C7BB13B405A18E615C6E9;jsessionid=DC81F27C1A01BEA89BD0E8E2A9F4D183